Reference

Dosing Comparison Table

Every compound in the dosing library against all five tiers of source data. A filled marker indicates that source tier is indexed; clicking the compound opens the full breakdown. Conflicting sources are never averaged into a single number.

Source Tier Legend

Official product dosing

Published human study doses

Published animal studies

Clinical / professional references

Community-reported ranges

Not Indexed / None

Compounds against the five kinds of dosing source
Compound	Route Discussed	Highest Level
Liraglutide	Subcutaneous injection	Official
Ipamorelin	Intravenous infusion; As described in the study's models	Human study
CJC-1295	Subcutaneous	Human study
BPC-157	Intra-articular injection	Human study
TB-500	—	Community
Melanotan II	Subcutaneous	Human study
Semaglutide	Subcutaneous injection once weekly; Subcutaneous	Official
Retatrutide	Subcutaneous injection	Human study
Tirzepatide	Subcutaneous injection once weekly; Subcutaneous	Official
Tesamorelin	Subcutaneous injection once daily; Subcutaneous	Official
Sermorelin	Intravenous (diagnostic) or subcutaneous (maintenance)	Human study
GHK-Cu	Topical dermal application	Human study

Liraglutide

Official

Source Tiers Present:

Official

Route: Subcutaneous injection

Open Liraglutide Dosing File →

Ipamorelin

Human study

Source Tiers Present:

Human studyAnimalCommunity

Route: Intravenous infusion, As described in the study's models

Open Ipamorelin Dosing File →

CJC-1295

Human study

Source Tiers Present:

Human studyClinical ref.Community

Route: Subcutaneous

Open CJC-1295 Dosing File →

BPC-157

Human study

Source Tiers Present:

Human studyCommunity

Route: Intra-articular injection

Open BPC-157 Dosing File →

TB-500

Community

Source Tiers Present:

Community

Open TB-500 Dosing File →

Melanotan II

Human study

Source Tiers Present:

Human studyCommunity

Route: Subcutaneous

Open Melanotan II Dosing File →

Semaglutide

Official

Source Tiers Present:

OfficialHuman study

Route: Subcutaneous injection once weekly, Subcutaneous

Open Semaglutide Dosing File →

Retatrutide

Human study

Source Tiers Present:

Human studyClinical ref.Community

Route: Subcutaneous injection

Open Retatrutide Dosing File →

Tirzepatide

Official

Source Tiers Present:

OfficialHuman study

Route: Subcutaneous injection once weekly, Subcutaneous

Open Tirzepatide Dosing File →

Tesamorelin

Official

Source Tiers Present:

OfficialHuman studyCommunity

Route: Subcutaneous injection once daily, Subcutaneous

Open Tesamorelin Dosing File →

Sermorelin

Human study

Source Tiers Present:

Human studyCommunity

Route: Intravenous (diagnostic) or subcutaneous (maintenance)

Open Sermorelin Dosing File →

GHK-Cu

Human study

Source Tiers Present:

Human studyCommunity

Route: Topical dermal application

Open GHK-Cu Dosing File →

This is an informational comparison reference, not a prescribing guide. Where a compound shows both an official dose and a community range, those numbers belong to different worlds — an approved pharmaceutical label and an unverified discussion — and are never blended. Detailed source records and primary citations live on each compound’s dosing reference page.